Clinical Trials Browser

Phase 3 × NSCLC × Carboplatin × Clear all

NCT06754644 2025-06-10

A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC

Phase 3 Recruiting

NSCLC

NCT05493501 2024-05-02

Aumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer

Phase 3 Terminated

8 enrolled 7 charts

NSCLC

NCT03656393 2018-09-04

RCTACSCNSCLC

Phase 3 Unknown

NSCLC